Jialiang Du

429 total citations
44 papers, 277 citations indexed

About

Jialiang Du is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Jialiang Du has authored 44 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 17 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Jialiang Du's work include Viral gastroenteritis research and epidemiology (11 papers), Rabies epidemiology and control (10 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Jialiang Du is often cited by papers focused on Viral gastroenteritis research and epidemiology (11 papers), Rabies epidemiology and control (10 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Jialiang Du collaborates with scholars based in China, United States and Canada. Jialiang Du's co-authors include Xiaoyan Tao, Chuanfei Yu, Qing Tang, Susan A. Nadin‐Davis, Zhihao Fu, Yueyue Liu, Lan Wang, Tai L. Guo, Guodong Liang and Guodong Liang and has published in prestigious journals such as Analytical Chemistry, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Jialiang Du

39 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jialiang Du China 10 129 80 76 65 43 44 277
Cindy R WalkerPeach United States 5 105 0.8× 24 0.3× 134 1.8× 55 0.8× 12 0.3× 6 297
Subhash V. Kapre India 13 146 1.1× 60 0.8× 67 0.9× 309 4.8× 80 1.9× 24 429
Jessica A. White United States 12 154 1.2× 18 0.2× 62 0.8× 68 1.0× 18 0.4× 25 292
A Daas Belgium 11 77 0.6× 45 0.6× 67 0.9× 112 1.7× 103 2.4× 53 345
Haiying Wang China 12 197 1.5× 94 1.2× 101 1.3× 100 1.5× 33 0.8× 34 381
Songsri Kasempimolporn Thailand 10 97 0.8× 143 1.8× 39 0.5× 116 1.8× 65 1.5× 25 274
В. В. Зверев Russia 8 100 0.8× 12 0.1× 77 1.0× 60 0.9× 16 0.4× 86 240
Amanda Phelps United Kingdom 11 169 1.3× 64 0.8× 88 1.2× 91 1.4× 5 0.1× 24 299
Jennifer Serwanga Uganda 10 219 1.7× 176 2.2× 101 1.3× 82 1.3× 9 0.2× 39 402
Golnaz Bahramali Iran 12 84 0.7× 25 0.3× 115 1.5× 146 2.2× 16 0.4× 49 348

Countries citing papers authored by Jialiang Du

Since Specialization
Citations

This map shows the geographic impact of Jialiang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialiang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialiang Du more than expected).

Fields of papers citing papers by Jialiang Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialiang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialiang Du. The network helps show where Jialiang Du may publish in the future.

Co-authorship network of co-authors of Jialiang Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jialiang Du. A scholar is included among the top collaborators of Jialiang Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialiang Du. Jialiang Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Zhen, Jialiang Du, Meng Li, et al.. (2025). Characterization of O-Glycosylation and N-Glycosylation in Bispecific Antibodies and Its Importance in Therapeutic Antibody Development. Pharmaceuticals. 18(10). 1538–1538.
2.
Gao, Xu, et al.. (2025). High sensitivity charge heterogeneity characterization of blinatumomab product by imaged capillary isoelectric focusing with native UV fluorescence detection. Journal of Pharmaceutical and Biomedical Analysis. 265. 117016–117016. 1 indexed citations
3.
Huang, Zhi‐Hao, et al.. (2025). Transcriptomic insights into the resistance mechanism of Penaeus vannamei against highly lethal Vibrio parahaemolyticus. Scientific Reports. 15(1). 13490–13490. 1 indexed citations
4.
Ni, Yizhao, et al.. (2025). Development and validation of a cell-based assay to determine the bioactivity of antibodies against CD39 targets. Journal of Pharmaceutical and Biomedical Analysis. 265. 117021–117021.
5.
Li, Meng, Zhe Jia, Chuanfei Yu, et al.. (2025). Establishment of a subvisible particle profile in ophthalmic recombinant fusion protein and antibody formulations to control and monitor drug quality. International Journal of Pharmaceutics. 675. 125500–125500.
6.
Du, Jialiang, et al.. (2024). A combination of multiple LC-MS approaches for the comprehensive characterization of cysteine-linked ADCs. Journal of Pharmaceutical and Biomedical Analysis. 248. 116331–116331. 2 indexed citations
7.
Du, Jialiang, et al.. (2024). Mass spectrometry study on SARS-CoV-2 recombinant vaccine with comprehensive separation techniques to characterize complex heterogeneity. Analytica Chimica Acta. 1297. 342349–342349. 8 indexed citations
9.
Liu, Jun, et al.. (2024). Novel identification of mAbs by Raman spectroscopy. Engineering Reports. 6(12). 2 indexed citations
10.
Du, Jialiang, et al.. (2024). Possibility of using the imaged capillary isoelectric method as a multi‐attribute method for bispecific antibodies. Electrophoresis. 45(19-20). 1665–1672. 2 indexed citations
11.
Wang, Wenbo, et al.. (2024). Developing a human monoclonal antibody combination CRM25 to prevent rabies after exposure. International Journal of Antimicrobial Agents. 64(6). 107383–107383. 1 indexed citations
12.
Yu, Chuanfei, et al.. (2024). A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates. Journal of Chromatography B. 1241. 124167–124167. 4 indexed citations
13.
Zhao, Jianhong, et al.. (2023). Genotypes Diversity of Acute Gastroenteritis Outbreaks Caused by Human Sapovirus — Beijing Municipality, China, 2015–2021. China CDC Weekly. 5(28). 625–631. 5 indexed citations
14.
Ma, Xiaoqi, Jianhong Zhao, Yue Zhang, et al.. (2023). Human rotavirus strains circulating among children in the capital of China (2018–2022)_ predominance of G9P[8] and emergence ofG8P[8]. Heliyon. 9(8). e18236–e18236. 11 indexed citations
15.
Du, Jialiang, et al.. (2022). Fingerprinting trimeric SARS-CoV-2 RBD by capillary isoelectric focusing with whole-column imaging detection. Analytical Biochemistry. 663. 115034–115034. 4 indexed citations
16.
Du, Jialiang, et al.. (2020). The endemic GII.4 norovirus‐like‐particle induced‐antibody lacks of cross‐reactivity against the epidemic GII.17 strain. Journal of Medical Virology. 93(6). 3974–3979. 4 indexed citations
18.
Zhang, Xu-Fu, Ming Tan, Lei Wang, et al.. (2020). Characterization of a hospital-based gastroenteritis outbreak caused by GII.6 norovirus in Jinshan, China. Epidemiology and Infection. 148. e289–e289. 13 indexed citations
19.
Du, Jialiang, Yueyue Liu, Yan Liu, et al.. (2016). Detailed analysis of BALB/c mice challenged with wild type rotavirus EDIM provide an alternative for infection model of rotavirus. Virus Research. 228. 134–140. 7 indexed citations
20.
Tang, Qing, Susan A. Nadin‐Davis, Shoufeng Zhang, et al.. (2010). Development of a reverse genetics system for a human rabies virus vaccine strain employed in China. Virus Research. 149(1). 28–35. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026